Xiujuan Chang

1.1k total citations
37 papers, 724 citations indexed

About

Xiujuan Chang is a scholar working on Hepatology, Epidemiology and Molecular Biology. According to data from OpenAlex, Xiujuan Chang has authored 37 papers receiving a total of 724 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Hepatology, 17 papers in Epidemiology and 7 papers in Molecular Biology. Recurrent topics in Xiujuan Chang's work include Liver Disease Diagnosis and Treatment (15 papers), Hepatocellular Carcinoma Treatment and Prognosis (14 papers) and Hepatitis B Virus Studies (8 papers). Xiujuan Chang is often cited by papers focused on Liver Disease Diagnosis and Treatment (15 papers), Hepatocellular Carcinoma Treatment and Prognosis (14 papers) and Hepatitis B Virus Studies (8 papers). Xiujuan Chang collaborates with scholars based in China, United States and India. Xiujuan Chang's co-authors include Yongping Yang, Jianhui Qu, Yinying Lu, Wenlin Bai, Chunping Wang, Linjing An, Xudong Gao, Min Lou, Zhen Zeng and Ke‐Qin Hu and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Hepatology.

In The Last Decade

Xiujuan Chang

37 papers receiving 711 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiujuan Chang China 13 345 217 209 132 110 37 724
Zhuolun Song China 15 275 0.8× 231 1.1× 181 0.9× 68 0.5× 83 0.8× 53 744
Michèle Egger Switzerland 4 320 0.9× 352 1.6× 253 1.2× 187 1.4× 250 2.3× 4 866
Mei ElGindi United States 9 227 0.7× 324 1.5× 193 0.9× 205 1.6× 151 1.4× 15 833
T Maass Germany 15 176 0.5× 229 1.1× 388 1.9× 112 0.8× 133 1.2× 25 720
Dipti Athavale United States 14 121 0.4× 178 0.8× 271 1.3× 95 0.7× 165 1.5× 24 659
Aastha Jindal Italy 5 173 0.5× 336 1.5× 203 1.0× 71 0.5× 83 0.8× 8 627
Timo Itzel Germany 13 114 0.3× 235 1.1× 232 1.1× 123 0.9× 110 1.0× 29 603
Shi Zuo China 14 174 0.5× 182 0.8× 484 2.3× 142 1.1× 221 2.0× 52 837
Kiyokazu Hiwatashi Japan 17 333 1.0× 187 0.9× 226 1.1× 317 2.4× 149 1.4× 34 913
Kunimaro Furuta Japan 17 298 0.9× 405 1.9× 293 1.4× 55 0.4× 131 1.2× 32 776

Countries citing papers authored by Xiujuan Chang

Since Specialization
Citations

This map shows the geographic impact of Xiujuan Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiujuan Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiujuan Chang more than expected).

Fields of papers citing papers by Xiujuan Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiujuan Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiujuan Chang. The network helps show where Xiujuan Chang may publish in the future.

Co-authorship network of co-authors of Xiujuan Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Xiujuan Chang. A scholar is included among the top collaborators of Xiujuan Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiujuan Chang. Xiujuan Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
He, Quanwei, Xiujuan Chang, Ran Xu, et al.. (2025). Global temporal trends and projections of hepatitis B-related cirrhosis among adolescents and young adults from 1990 to 2035: an analysis based on the global burden of disease study 2021. Frontiers in Public Health. 12. 1494388–1494388. 1 indexed citations
2.
Zhang, Yu, Wei Luo, Caihong Lv, et al.. (2024). HAND2-AS1 Promotes Ferroptosis to Reverse Lenvatinib Resistance in Hepatocellular Carcinoma by TLR4/NOX2/DUOX2 Axis. Current Cancer Drug Targets. 25(2). 144–158. 8 indexed citations
3.
Zhong, Yanwei, Xiujuan Chang, Zihan Zhao, et al.. (2024). Bacteroides fragilis capsular polysaccharide A ameliorates ulcerative colitis in rat by recovering intestinal barrier integrity and restoring gut microbiota. Frontiers in Pharmacology. 15. 1402465–1402465. 7 indexed citations
4.
Yu, Shumin, Xiujuan Chang, Xiaodong Jia, et al.. (2024). Serum high-density lipoprotein cholesterol levels predict early recurrence and prognosis of intrahepatic cholangiocarcinoma after surgical resection. Heliyon. 10(11). e32113–e32113. 1 indexed citations
5.
Chang, Xiujuan, et al.. (2023). Population Sensitive to Lenvatinib Plus Anti-PD-1 for Unresectable Hepatocellular Carcinoma Infected with Hepatitis B Virus. Journal of Hepatocellular Carcinoma. Volume 10. 847–861. 1 indexed citations
6.
7.
8.
Chang, Xiujuan, Wei Zhang, Guojie Zhang, et al.. (2022). The best benefit population treated with lenvatinib plus anti-PD-1 for unresectable hepatocellular carcinoma.. Journal of Clinical Oncology. 40(16_suppl). e16152–e16152. 1 indexed citations
9.
Zhang, Wei, Xiujuan Chang, Linjing An, et al.. (2021). Microarray Data Mining and Preliminary Bioinformatics Analysis of Hepatitis D Virus‐Associated Hepatocellular Carcinoma. BioMed Research International. 2021(1). 1093702–1093702. 10 indexed citations
10.
Chang, Xiujuan, Yan Chen, Zujiang Yu, et al.. (2019). On-treatment monitoring of liver fibrosis with serum hepatitis B core-related antigen in chronic hepatitis B. World Journal of Gastroenterology. 25(32). 4764–4778. 16 indexed citations
11.
Dong, Zheng, Xiujuan Chang, Cuihong Zhang, et al.. (2018). Protective effect of the total flavonoids from Apocynum venetum L. on carbon tetrachloride-induced hepatotoxicity in vitro and in vivo. Journal of Physiology and Biochemistry. 74(2). 301–312. 31 indexed citations
12.
Dong, Zheng, Ruizhao Qi, Xiaodong Guo, et al.. (2016). MiR-223 modulates hepatocellular carcinoma cell proliferation through promoting apoptosis via the Rab1-mediated mTOR activation. Biochemical and Biophysical Research Communications. 483(1). 630–637. 41 indexed citations
13.
Zhang, Yanjun, et al.. (2016). Optimization of alcohol precipitation technology of Biqiu granules based on index components and pharmacodynamics. China Journal of Chinese Materia Medica. 41(24). 4598–4604. 1 indexed citations
14.
Chang, Wenju, Lujun Song, Xiujuan Chang, et al.. (2016). Early activated hepatic stellate cell-derived paracrine molecules modulate acute liver injury and regeneration. Laboratory Investigation. 97(3). 318–328. 25 indexed citations
15.
Cao, Zeyu, Xiujuan Chang, Zhongpeng Zhao, Liang Cao, & Wei Xiao. (2015). Antiviral effects of Reduning injection against Enterovirus 71 and possible mechanisms of action. Chinese Journal of Natural Medicines. 13(12). 881–888. 11 indexed citations
16.
Wang, Chunping, Hong Wang, Xiaodong Guo, et al.. (2014). Hepatic Angiomyolipoma Mimicking Hepatocellular Carcinoma. Medicine. 93(28). e194–e194. 20 indexed citations
17.
Rong, Guanghua, Wenlin Bai, Dong Zheng, et al.. (2014). Cryotherapy for cirrhosis-based hepatocellular carcinoma: a single center experience from 1595 treated cases. Frontiers of Medicine. 9(1). 63–71. 9 indexed citations
18.
Yang, Yongping, Jianhui Qu, Xiujuan Chang, et al.. (2013). High intratumoral metastasis-associated in colon cancer-1 expression predicts poor outcomes of cryoablation therapy for advanced hepatocellular carcinoma. Journal of Translational Medicine. 11(1). 41–41. 35 indexed citations
19.
Chang, Xiujuan. (2012). Estimation Model of Plane Manhours in Manufacture Based on Partial Least-squares Regression. Acta Aeronautica et Astronautica Sinica. 1 indexed citations
20.
Yang, Yongping, Chunping Wang, Yinying Lu, et al.. (2011). Outcomes of ultrasound‐guided percutaneous argon‐helium cryoablation of hepatocellular carcinoma. Journal of Hepato-Biliary-Pancreatic Sciences. 19(6). 674–684. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhuolun Song Breakdown of academic impact, for papers by Michèle Egger Breakdown of academic impact, for papers by Mei ElGindi Breakdown of academic impact, for papers by T Maass Breakdown of academic impact, for papers by Dipti Athavale Breakdown of academic impact, for papers by Aastha Jindal Breakdown of academic impact, for papers by Timo Itzel Breakdown of academic impact, for papers by Shi Zuo Breakdown of academic impact, for papers by Kiyokazu Hiwatashi Breakdown of academic impact, for papers by Kunimaro Furuta
Rankless by CCL
2026